AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.445

-0.005-0.34%

Volume:408.47K

Turnover:588.87K

Market Cap:518.09M

PE:-8.16

High:1.465

Open:1.460

Low:1.410

Close:1.450

52wk High:2.250

52wk Low:1.275

Shares:358.54M

Float Shares:275.05M

Volume Ratio:1.11

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.177

EPS(LYR):-0.082

ROE:-143.12%

ROA:-26.53%

PB:12.39

PE(LYR):-17.62

Loading ...

Overview Company News Filings

Imricor Medical Systems Submits Steerable Introducers for US FDA Clearance

MT Newswires Live

Imricor Medical Systems, Inc-imricor Submits All Remaining 510(k) Devices to FDA

THOMSON REUTERS

Imricor Medical Systems - Submits Navtrac and Navtrac-mr Steerable Introducers for FDA 510(k) Clearance

THOMSON REUTERS

Imricor Medical Systems, Receives FDA 510(k) Clearance for Northstar Pediatric Label Expansion

Imricor Secures US FDA Clearance for Pediatric Expansion of NorthStar, Vision-MR Systems

MT Newswires Live

Imricor Medical Systems, - Receives FDA 510(k) Clearance for Vision-mr Diagnostic Catheter Pediatric Label Expansion

THOMSON REUTERS

Imricor Medical Systems Files US Registration Statement for About 39 Million Class A Shares

MT Newswires Live

BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review

Imricor Submits Third US FDA Premarket Approval Module for Vision-MR Ablation System

MT Newswires Live

Imricor Medical Systems, Inc-Submission of the Third Pma Module to the US FDA for Review

THOMSON REUTERS

Imricor Medical Systems, - Submission Includes Vision-Mr Ablation Catheter 2, RF-5000 Generator, RF-5000 Tubing Set

THOMSON REUTERS

Imricor Medical Systems Granted Waiver From Certain ASX Listing Rules After Becoming US Public Reporting Company

MT Newswires Live

Imricor Medical Systems Inc - Granted ASX Waiver From Listing Rules Effective 26 May 2026

THOMSON REUTERS

Imricor Medical Systems Inc-Update - Notification Regarding Unquoted Securities - Imr

THOMSON REUTERS

BUZZ-Australia's Imricor Medical Systems slips on discounted placement

Imricor Medical Systems Secures AU$60 Million in Institutional Placement

MT Newswires Live

BRIEF-Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per Share

Imricor Medical Systems - to Raise a$60.0 Mln at an Offer Price of a$1.85 per Share

THOMSON REUTERS

BRIEF-Imricor Medical Systems Seeks Trading Halt Pending Announcement On Proposed Capital Raising

Imricor Medical Systems Inc - Trading Halt Requested Pending Announcement on Proposed Capital Raising

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/IMR.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.445,"timestamp":1791436320000,"preClose":1.45,"halted":0,"volume":408468,"delay":0,"changeRate":-0.003448275862068892,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":358542497,"eps":-0.177068,"marketStatus":"Closed","change":-0.005,"latestTime":"10-08 16:12:00 AEDT","open":1.46,"high":1.465,"low":1.41,"amount":588869,"amplitude":0.037931,"askPrice":1.46,"askSize":6250,"bidPrice":1.435,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-0.177068,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":1.45,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":1.112621,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":1.45,"auctionPrice":1.445,"auctionVolume":68619,"auctionTime":1791436200787,"referencePrice":1.445,"referenceTime":1791438120442,"auction":3,"marketStatus":"盘后竞价","timestamp":1791436200787}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-26.53%","roe":"-143.12%","lyrEps":-0.082003,"volumeRatio":1.112621,"shares":358542497,"dividePrice":0,"high":1.465,"amplitude":0.037931,"preClose":1.45,"low":1.41,"week52Low":1.275,"pbRate":"12.39","psRate":"2999.98","week52High":2.25,"institutionHeld":0,"latestPrice":1.445,"committee":-0.111111,"eps":-0.177068,"divideRate":0,"volume":408468,"delay":0,"ttmEps":-0.177068,"open":1.46,"prevYearClose":1.53,"prevWeekClose":1.505,"prevMonthClose":1.585,"prevQuarterClose":1.585,"fiveDayClose":1.56,"twentyDayClose":1.81,"sixtyDayClose":1.68,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786320000000,"name":null,"time":"","dateTimestamp":1786284000000,"actualEps":null},{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652226517","title":"Imricor Medical Systems Submits Steerable Introducers for US FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2652226517","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652226517?lang=en_us&edition=fundamental","pubTime":"2026-07-20 09:23","pubTimestamp":1784510608,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  submitted its NavTrac and NavTrac-MR steerable introducers for market clearance under the US Food and Drug Administration's 510 premarket notification pathway, according to a Monday filing with the Australian bourse.The devices are used to insert and guide a range of cardiovascular catheters into the heart during certain medical procedures, per the filing.Imricor said it has now completed 14 of the 15 FDA submissions required to establish a full product platform in the US.The company's shares gained 1% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","LABU","BK4585","BK7508","IMR.AU","BK7503","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652689642","title":"Imricor Medical Systems, Inc-imricor Submits All Remaining 510(k) Devices to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2652689642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652689642?lang=en_us&edition=fundamental","pubTime":"2026-07-20 07:25","pubTimestamp":1784503519,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nTUE9V0D1F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7508","IMR.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652268961","title":"Imricor Medical Systems - Submits Navtrac and Navtrac-mr Steerable Introducers for FDA 510(k) Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652268961?lang=en_us&edition=fundamental","pubTime":"2026-07-20 07:25","pubTimestamp":1784503519,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nTUE9V0D1F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IMR.AU","BK7503","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648257852","title":"Imricor Medical Systems, Receives FDA 510(k) Clearance for Northstar Pediatric Label Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2648257852","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648257852?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:29","pubTimestamp":1782955792,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems, Receives FDA 510 Clearance For Northstar Pediatric Label ExpansionJuly 2 -Imricor Medical Systems, IncIMR.AX:RECEIVES FDA 510 CLEARANCE FOR NORTHSTAR PEDIATRIC LABEL EXPANSIONRECEIVES FDA 510 CLEARANCE FOR VISION-MR DIAGNOSTIC CATHETER PEDIATRIC LABEL EXPANSIONCLEARED TO MARKET NORTHSTAR AND VISION-MR DIAGNOSTIC CATHETER FOR ALL AGES IN USFurther company coverage:IMR.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN433190:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IMR.AU","BK7503","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648613522","title":"Imricor Secures US FDA Clearance for Pediatric Expansion of NorthStar, Vision-MR Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2648613522","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648613522?lang=en_us&edition=fundamental","pubTime":"2026-07-02 07:24","pubTimestamp":1782948261,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  received US Food and Drug Administration  clearance to expand pediatric use of its NorthStar iMR navigation system and Vision-MR diagnostic catheter, according to a Thursday Australian bourse filing.The approvals permit both devices to be marketed to patients of all ages, including children and young adults, especially those receiving care at more than 250 children's hospitals across the US, per the filing.The company said its interventional magnetic resonance imaging approach may be beneficial in pediatric cardiology for congenital heart defects requiring repeated catheterizations, eliminating exposure to ionizing X-ray radiation.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","LABU","BK7508","BK4585","BK7007","BK4588","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648524483","title":"Imricor Medical Systems, - Receives FDA 510(k) Clearance for Vision-mr Diagnostic Catheter Pediatric Label Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2648524483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648524483?lang=en_us&edition=fundamental","pubTime":"2026-07-02 06:33","pubTimestamp":1782945213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN433190:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7508","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646825833","title":"Imricor Medical Systems Files US Registration Statement for About 39 Million Class A Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646825833","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646825833?lang=en_us&edition=fundamental","pubTime":"2026-06-26 08:04","pubTimestamp":1782432292,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  filed a registration statement with the US Securities and Exchange Commission for 38.9 million class A common shares, according to a Friday notice on the Australian bourse.The shares are issuable under options the company previously granted as part of an equity incentive plan, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","IMR.AU","BK7508","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642477054","title":"BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2642477054","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642477054?lang=en_us&edition=fundamental","pubTime":"2026-06-11 09:28","pubTimestamp":1781141339,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For ReviewJune 11  - Imricor Medical Systems, Inc IMR.AX:SUBMISSION OF THE THIRD PMA MODULE TO THE US FDA FOR REVIEWSUBMISSION INCLUDES VISION-MR ABLATION CATHETER 2, RF-5000 GENERATOR, RF-5000 TUBING SETFurther company coverage: IMR.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nTUEQP6L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7503","IMR.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642741754","title":"Imricor Submits Third US FDA Premarket Approval Module for Vision-MR Ablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2642741754","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642741754?lang=en_us&edition=fundamental","pubTime":"2026-06-11 07:42","pubTimestamp":1781134928,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  has filed the third module of its premarket approval application with the US Food and Drug Administration , covering non-clinical bench testing for its Vision-MR Ablation Catheter 2.0, RF-5000 Ablation Generator, and irrigation tubing set, according to a Thursday Australian bourse filing.The submission contains testing data covering product performance, sterile shelf life, packaging integrity, software testing, electrical safety, electromagnetic compatibility, magnetic resonance safety, and usability, per the filing.The company is streamlining FDA approval via a modular review process while pursuing additional device clearances, with three products already cleared, including NorthStar, Vision-MR Diagnostic Catheter, and Vision-MR Diagnostic Catheter Cable, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","IMR.AU","BK7508","LABU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642710424","title":"Imricor Medical Systems, Inc-Submission of the Third Pma Module to the US FDA for Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2642710424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642710424?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:55","pubTimestamp":1781132143,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUEQP6L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7007","BK7503","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642471023","title":"Imricor Medical Systems, - Submission Includes Vision-Mr Ablation Catheter 2, RF-5000 Generator, RF-5000 Tubing Set","url":"https://stock-news.laohu8.com/highlight/detail?id=2642471023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642471023?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:55","pubTimestamp":1781132143,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUEQP6L8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7007","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638552965","title":"Imricor Medical Systems Granted Waiver From Certain ASX Listing Rules After Becoming US Public Reporting Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2638552965","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638552965?lang=en_us&edition=fundamental","pubTime":"2026-05-27 07:52","pubTimestamp":1779839554,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  was granted a waiver from certain ASX listing rules, effective Tuesday, in order to align its ASX periodic reporting with the reporting requirements in its home jurisdiction in the US, according to a Wednesday Australian bourse filing.The company said its registration statement on Form 10 became effective on May 17, making it a US public reporting company, subject to the periodic reporting requirements, including requirements to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K with the US Securities and Exchange Commission .Imricor will not be required to lodge an Appendix 4D, an Appendix 4E, and an Appendix 4C.The waiver will cease to apply if Imricor ceases to be subject to an obligation to file Forms 10-K and Forms 10-Q with the US SEC.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","SEC.AU","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638526947","title":"Imricor Medical Systems Inc - Granted ASX Waiver From Listing Rules Effective 26 May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638526947","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638526947?lang=en_us&edition=fundamental","pubTime":"2026-05-27 07:13","pubTimestamp":1779837193,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUE6MMLK1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7503","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637871467","title":"Imricor Medical Systems Inc-Update - Notification Regarding Unquoted Securities - Imr","url":"https://stock-news.laohu8.com/highlight/detail?id=2637871467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637871467?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:33","pubTimestamp":1779320022,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUEBHFCQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","IMR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632598005","title":"BUZZ-Australia's Imricor Medical Systems slips on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632598005","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632598005?lang=en_us&edition=fundamental","pubTime":"2026-05-04 13:06","pubTimestamp":1777871211,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor Medical Systems slips on discounted placement** Shares of Imricor Medical Systems IMR.AX fall as much as 6.3% to A$1.85, their lowest level since April 14** On track to mark worst session since April 22** Medical device developer receives firm commitments to raise A$60 million  via placement** Offer price of A$1.85 represents a 6.3% discount to its last close** Proceeds will be used to accelerate Imricor’s growth strategy, including launching NorthStar in the U.S., and others, co says** Up 22.6% YTD, including session's moves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL6N41H04I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632598487","title":"Imricor Medical Systems Secures AU$60 Million in Institutional Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632598487","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632598487?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:24","pubTimestamp":1777857871,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  has secured firm commitments from new and existing institutional and sophisticated investors to raise AU$60 million through the issue of 32.4 million Chess depositary interests  at AU$1.85 per CDI, reflecting a 7.7% discount to its 10-day volume-weighted average price, according to a Monday Australian bourse filing.The new CDIs will be issued in a single tranche under the company's existing placement capacity and will rank equally with existing CDIs, per the filing.Settlement is expected on Thursday, with the new CDIs scheduled for issuance and set to begin trading on the Australian Securities Exchange on Friday, the filing said.The funds will be used to accelerate the company's growth strategy, including launching NorthStar in the US, advancing regulatory approvals for its full electrophysiology platform, completing key clinical programs, progressing pulsed field ablation development, and supporting expansion in the Middle East and other target markets, the fi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7508","BK7503","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632810299","title":"BRIEF-Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632810299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632810299?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:20","pubTimestamp":1777857641,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per ShareMay 4 (Reuters) - Imricor Medical Systems Inc IMR.AX:TO RAISE A$60.0 MILLION AT AN OFFER PRICE OF A$1.85 PER SHAREFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41E0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7007","BK7503","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632989854","title":"Imricor Medical Systems - to Raise a$60.0 Mln at an Offer Price of a$1.85 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632989854","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632989854?lang=en_us&edition=fundamental","pubTime":"2026-05-04 07:13","pubTimestamp":1777850001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260503:nFWN41E0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","IMR.AU","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631575958","title":"BRIEF-Imricor Medical Systems Seeks Trading Halt Pending Announcement On Proposed Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2631575958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631575958?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:01","pubTimestamp":1777507296,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Seeks Trading Halt Pending Announcement On Proposed Capital RaisingApril 30 (Reuters) - Imricor Medical Systems Inc IMR.AX:IMRICOR MEDICAL SYSTEMS INC - TRADING HALT REQU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1UE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7007","IMR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631759835","title":"Imricor Medical Systems Inc - Trading Halt Requested Pending Announcement on Proposed Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2631759835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631759835?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:00","pubTimestamp":1777507210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1UE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","IMR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}